Halozyme Therapeutics, Inc. (HALO)
San Diego, CA
Total Compensation for Fiscal Year Ending in 2024: $12,741,421
| Salary | $960,000 |
|---|---|
| Bonus | $0 |
| Value of Stock Awards | $8,840,059 |
| Value of Option Awards | $1,560,006 |
| Non-Equity Incentive Plan Compensation | $1,363,392 |
| Change in Pension Value and Deferred Compensation Earnings | $0 |
| All Other Compensation | $17,964 |
| Total | $12,741,421 |
Halozyme Therapeutics, Inc. disclosed its CEO pay was
58
times its median employee's pay for the fiscal year ending in 2024.
How Do You Compare?
